Hengenix Biotech, Inc.

Hengenix Biotech, Inc. is located in Fremont, United States on 46421 Landing Pkwy. Hengenix Biotech, Inc. is rated 3 out of 5 in the category biotechnology in United States. Located in Fremont, CA, Hengenix Biotech, Inc. (Hengenix) focuses on developing and delivering safe, effective and affordable medicine to treat a range of chronic and life-threatening diseases. Hengenix is affiliated with Shanghai Henlius Biotech (复宏汉霖), a top biopharma company in China co-founded in 2009 by two American biopharmaceutical veterans (Dr. Scott Liu and Dr. Weidong Jiang). Henlius’ diverse pipeline of over 20 innovative monoclonal antibodies (mAb) includes 汉利康 (HLX01, rituximab), the first commercially launched biosimilar in China, 2 products under NDA review for potential 2020 launch, and over 20 clinical studies for 10 products and 8 combination therapies worldwide. Our goal at Hengenix is to accelerate the discovery and development of innovative biologics (such as monoclonal and bispecific antibody) through technical and operational excellence and to build a leading immuno-oncology franchise with a diverse and distinguished product portfolio. We aim to be a globally trusted biotech company dedicated to bringing affordable, innovative treatment to patients with unmet medical needs worldwide. Hengenix: https://hengenix.com/ Henlius: http://www.henlius.com/en/index.html